- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -0.24%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 40 SMA
- 500 SMA
Returns
CAGR returns till date
CAGR returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth and its peers as on 13 November, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth | 21.6% | -0.24% | 1.23% | 7% | 0.76% | 19.66% | 20.71% | 15.89% | 21.88% | - |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -9.29% | -0.27% | 0.2% | 3.18% | -6.26% | -10.5% | 4.93% | 8.92% | 13.82% | 14.25% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | 0.75% | -0.5% | 1.2% | 9.63% | 2.07% | 1.58% | 11.19% | 7.88% | 12.9% | 12.67% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 29.68% | -0.01% | 3.26% | 10.03% | 4.42% | 26.07% | 25.42% | 20.65% | 26.17% | 15.92% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | 3.39% | -0.04% | 1.28% | 6.76% | -0.65% | 3.49% | 12.47% | 14.96% | 19.21% | 15.81% |
| SBI COMMA Fund - DIRECT PLAN - Growth | 4.37% | -0.55% | 0.42% | 4.29% | -2.46% | 6.57% | 14.27% | 9.88% | 18.09% | 14.96% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | 57.54% | 20.14% | -11.24% | 40.42% | 37.69% | -3.36% |
Discrete returns (monthly)
| Month | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 | Sep 2026 | Oct 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -3.8% | 4.81% | -3.21% | 5.19% | 3.93% | 6.31% | 5.11% | 1.75% | -2.77% | -0.76% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|---|
| Returns | 14.67% | 8.01% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 96.40% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 3.60% |
Equity
| Name | Symbol / ISIN | Sector | Weight % | Other links |
|---|---|---|---|---|
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 9.57% | |
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 9.19% | |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 6.85% | |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 5.16% | |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 4.53% | |
| Ajanta Pharma Ltd. | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 4.22% | |
| Sai Life Sciences Ltd. | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 4.20% | |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 3.41% | |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 3.10% | |
| Abbott India Ltd. | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 3.03% | |
| Emcure Pharmaceuticals Ltd. | EMCURE (INE168P01015) | Pharmaceuticals & Biotechnology | 2.99% | |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 2.79% | |
| IPCA Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 2.71% | |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 2.63% | |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 2.23% | |
| Corona Remedies Ltd. | CORONA (INE02ZQ01018) | Pharmaceuticals & Biotechnology | 2.17% | |
| Dr. Lal Path labs Ltd. | LALPATHLAB (INE600L01024) | Healthcare Services | 2.10% | |
| Thyrocare Technologies Ltd. | THYROCARE (INE594H01019) | Healthcare Services | 1.94% | |
| Procter & Gamble Health Ltd. | PGHL (INE199A01012) | Pharmaceuticals & Biotechnology | 1.84% | |
| Jupiter Life Line Hospitals Ltd. | (INE682M01020) | Healthcare Services | 1.76% | |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 1.69% | |
| Metropolis Healthcare Ltd. | METROPOLIS (INE112L01020) | Healthcare Services | 1.55% | |
| Shilpa Medicare Ltd. | SHILPAMED (INE790G01031) | Pharmaceuticals & Biotechnology | 1.27% | |
| Piramal Pharma Ltd. | PPLPHARMA (INE0DK501011) | Pharmaceuticals & Biotechnology | 1.24% | |
| Pfizer Ltd. | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 1.19% | |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 1.19% | |
| Sanofi Consumer Healthcare India Ltd. | SANOFICONR (INE0UOS01011) | Pharmaceuticals & Biotechnology | 1.18% | |
| Anthem Biosciences Ltd. | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 1.15% | |
| Manipal Health Enterprises Ltd | (INE459N01021) | Healthcare Services | 1.12% | |
| Vijaya Diagnostic Centre Ltd. | VIJAYA (INE043W01024) | Healthcare Services | 1.08% | |
| Dr. Reddy's Laboratories Ltd. | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 1.04% | |
| Suraksha Diagnostic Ltd. | SURAKSHA (INE877V01027) | Healthcare Services | 1.03% | |
| Natco Pharma Ltd. | NATCOPHARM (INE987B01026) | Pharmaceuticals & Biotechnology | 0.92% | |
| Glaxosmithkline Pharmaceuticals Ltd. | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 0.90% | |
| Medi Assist Healthcare Services Ltd. | MEDIASSIST (INE456Z01021) | Insurance | 0.78% | |
| Vinati Organics Ltd. | VINATIORGA (INE410B01037) | Chemicals & Petrochemicals | 0.77% | |
| Syngene International Ltd. | SYNGENE (INE398R01022) | Healthcare Services | 0.69% | |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 0.66% | |
| Jubilant Pharmova Ltd. | JUBLPHARMA (INE700A01033) | Pharmaceuticals & Biotechnology | 0.50% |
Portfolio data is as on date 31 August, 2026
NAV history
Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 13 November, 2026 | 41.26 | -0.24% |
| 12 November, 2026 | 41.36 | -0.36% |
| 11 November, 2026 | 41.51 | -0.1% |
| 9 November, 2026 | 41.55 | 1.94% |
| 6 November, 2026 | 40.76 | 0.92% |
| 5 November, 2026 | 40.39 | 0.35% |
| 4 November, 2026 | 40.25 | 1.64% |
| 3 November, 2026 | 39.60 | 0.71% |
| 2 November, 2026 | 39.32 | 0.1% |
| 30 October, 2026 | 39.28 | 0.59% |
| 29 October, 2026 | 39.05 | 0.28% |
| 28 October, 2026 | 38.94 | 1.09% |
| 27 October, 2026 | 38.52 | 2.01% |
| 26 October, 2026 | 37.76 | 1.29% |
| 23 October, 2026 | 37.28 | -0.61% |
| 22 October, 2026 | 37.51 | 0.19% |
| 21 October, 2026 | 37.44 | -0.45% |
| 19 October, 2026 | 37.61 | -1.05% |
| 16 October, 2026 | 38.01 | -0.5% |
| 15 October, 2026 | 38.20 | -0.16% |
| 14 October, 2026 | 38.26 | -0.78% |
| 13 October, 2026 | 38.56 | -0.26% |
| 12 October, 2026 | 38.66 | -0.03% |
| 9 October, 2026 | 38.67 | 0.7% |
| 8 October, 2026 | 38.40 | -2.39% |
| 7 October, 2026 | 39.34 | -0.48% |
| 6 October, 2026 | 39.53 | 0.79% |
| 5 October, 2026 | 39.22 | -1.01% |
| 1 October, 2026 | 39.62 | -0.25% |
| 30 September, 2026 | 39.72 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The latest NAV of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth is 41.26 as on 13 November, 2026.What are YTD (year to date) returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The YTD (year to date) returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth are 21.6% as on 13 November, 2026.What are 1 year returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The 1 year returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth are 19.66% as on 13 November, 2026.What are 3 year CAGR returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The 3 year annualized returns (CAGR) of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth are 20.71% as on 13 November, 2026.What are 5 year CAGR returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The 5 year annualized returns (CAGR) of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth are 15.89% as on 13 November, 2026.What are top 10 holdings of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
Top 10 holdings of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth are:- Torrent Pharmaceuticals Ltd.
- Sun Pharmaceutical Industries Ltd.
- Apollo Hospitals Enterprise Ltd.
- Cipla Ltd.
- Aurobindo Pharma Ltd.
- Ajanta Pharma Ltd.
- Sai Life Sciences Ltd.
- Mankind Pharma Ltd.
- Lupin Ltd.
- Abbott India Ltd.
- Emcure Pharmaceuticals Ltd.
What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)Holding period Tax rate Less than 1 year (STCG) 20% More than 1 year (LTCG) Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.